Amandeep Salhotra

Trials

Studies that name Amandeep Salhotra as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:53 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07733141 · Mindfulness Intervention to Reduce Patient Reported Symptoms in Patients With Chronic Graft-Versus-Host Disease

  City of Hope Medical Center · recruiting · Chronic Graft Versus Host Disease, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm · principal investigator
• Ph1
  NCT07133997 · Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia

  City of Hope Medical Center · recruiting · Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia · principal investigator
• Ph1
  NCT07025538 · Biomarker-Guided Ruxolitinib for the Prevention of Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

  City of Hope Medical Center · recruiting · Hematopoietic and Lymphatic System Neoplasm · principal investigator
• Ph1
  NCT06996119 · Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

  City of Hope Medical Center · recruiting · Acute Myeloid Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome · principal investigator
• Ph1
  NCT06543381 · Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant

  City of Hope Medical Center · recruiting · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome · principal investigator
• Ph1
  NCT06195891 · Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

  City of Hope Medical Center · suspended · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
• Ph1
  NCT05993611 · Allogeneic CD6 Chimeric Antigen Receptor T Regulatory Cells (CD6-CAR Tregs) for the Treatment of Patients With Chronic Graft Versus Host Disease After Allogeneic Hematopoietic Cell Transplantation

  City of Hope Medical Center · suspended · Chronic Graft Versus Host Disease, Hematologic and Lymphocytic Disorder, Steroid Refractory Graft Versus Host Disease · principal investigator
• Ph1
  NCT04212416 · Leflunomide in Treating Patients With Steroid Dependent Chronic Graft Versus Host Disease

  City of Hope Medical Center · active not recruiting · Chronic Graft Versus Host Disease, Steroid Refractory Graft Versus Host Disease · principal investigator
• Ph2
  NCT03728335 · Enasidenib (AG-221) Maintenance Post Allogeneic HCT in Patients With IDH2 Mutation

  City of Hope Medical Center · active not recruiting · Acute Myeloid Leukemia · principal investigator
• Ph2
  NCT03007238 · Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease

  City of Hope Medical Center · completed · Chronic Graft Versus Host Disease · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026
  Named on NCT07733141, NCT07133997, NCT07025538, NCT06996119, NCT06543381, NCT06195891, NCT05993611